Cover Image

Survival Outcomes for Rural Patients With Advanced Prostate Cancer: A SEER Investigation

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Liang G. Qu, J Bailey Vaselkiv, Marlon Perera, Lorelei Mucci
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	The Prostate
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Gene Expression Tumor Signature Optimizing Partial Area‐Under‐the‐Curve (pAUC) to Improve Specificity for Indolent Prostate Cancer
by: Travis A. Gerke, et al.
Published: (2026)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
by: Yifu Shi, et al.
Published: (2025)

Smoking Behavior Is Associated With an Altered Immune Landscape in Prostate Cancer: Implications for Patient Outcomes
by: Amod Sharma, et al.
Published: (2026)

Socioeconomic and Demographic Factors in Genetic Testing Utilization Among Advanced Prostate Cancer Patients
by: Alexandra T. Skowron, et al.
Published: (2026)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
by: Tatsuya Shimomura, et al.
Published: (2026)

Progression‐Free Survival Prediction Performance of ChatGPT: Analysis With Real Life Data in Early and Locally Advanced Prostate Cancer
by: Engin Eren Kavak, et al.
Published: (2025)

Genetic Testing Among Black and White Patients With Advanced Prostate Cancer: A Retrospective Analysis of Testing Utilization and Referral Patterns
by: Kyle C. McElyea, et al.
Published: (2025)

Impact of Testosterone Recovery on Oncologic Outcomes in High‐Risk, Localized Prostate Cancer
by: Trevor C. Hunt, et al.
Published: (2025)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
by: Charly Bâcle, et al.
Published: (2025)

Comprehensive Genomic Profiling Testing for Castration‐Resistant Prostate Cancer in Advanced Elderly Patients: A Single‐Center Retrospective Cohort Study
by: Takafumi Fukushima, et al.
Published: (2025)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
by: Elizabeth Robinson, et al.
Published: (2025)

Genomic and Clinical Impact of Smoking on Therapeutic Outcomes in Prostate Cancer: A Public Databases Analysis
by: Tomoya Hatayama, et al.
Published: (2026)

Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate‐Risk Prostate Cancer Patients With Node‐Negative PSMA PET
by: Baris Esen, et al.
Published: (2025)

Perioperative Safety and Early Oncologic Outcomes of Salvage Irreversible Electroporation for Radiorecurrent Prostate Cancer
by: Jarrett Noakes, et al.
Published: (2026)

Number of Prescription Medications and Overall Survival in Metastatic Castrate‐Resistant Prostate Cancer
by: Carley R. Pickett, et al.
Published: (2024)

Association of Weight Loss and BMI on PSA Levels and Overall Survival in Veterans With Metastatic Castrate‐Resistant Prostate Cancer
by: Nicholas Fedele, et al.
Published: (2025)

Prognostic Nutritional Index as a Biomarker in Metastatic Hormone‐Sensitive Prostate Cancer: Impact on Survival and Treatment Optimization
by: Muhammet Bekir Hacioglu, et al.
Published: (2025)

Genetics‐Driven, Intensity‐Modulated Adaptive Management of Patients With Metastatic Prostate Cancer
by: Reynier D. Rodriguez Rosales, et al.
Published: (2025)

Outcome Differences Between Subgroups of Favorable Intermediate Risk Prostate Cancer After Radical Prostatectomy
by: Matthew T. Steidle, et al.
Published: (2026)

Determinants of the Cost of Illness in Iranian Prostate Cancer Patients
by: Ramin Ravangard, et al.
Published: (2026)

Long‐Term Oncological Outcomes of Robot‐Assisted Radical Prostatectomy for Clinically Localized Grade Groups 4 and 5 Prostate Cancers Diagnosed on Prostate Biopsy
by: Victor Sandoval, et al.
Published: (2025)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
by: Andrea K. Miyahira, et al.
Published: (2024)

pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy
by: Piotr Bialas, et al.
Published: (2024)

Castration Resistance Accelerates Prostate Cancer Kinetics
by: Sheila Jonnatan, et al.
Published: (2026)

Treatment Noncompletion and Shorter Radiation Regimens Among US Patients With Prostate Cancer: A Focus on Asian American and Pacific Islander Patients
by: Rohit V. Mantena, et al.
Published: (2025)

Real‐World Overall Survival Comparison of Enzalutamide and Abiraterone In First‐ and Second‐Line Setting of Metastatic Castration‐Resistant Prostate Cancer
by: András Horváth, et al.
Published: (2025)

Outcome of Subsequent Therapies After 177Lu‐Vipivotide Tetraxetan for Metastatic Castrate‐Resistant Prostate Cancer: A Tertiary Cancer Center Experience
by: Meryam Losee, et al.
Published: (2025)

Spatial Robustness of Prostate Cancer Biomarkers Evaluated by Spatial Transcriptomics
by: Kristofer G. Taylor, et al.
Published: (2026)

Evidence and Rationale for Prostate Cancer Screening
by: Takeshi Takahashi
Published: (2025)

Directed Evolution Restored Castrate Sensitivity in a Patient With Castrate Resistant Metastatic Prostate Cancer
by: Robert A. Gatenby, et al.
Published: (2025)

Clinicopathological Significance of Extranodal Adipose Tissue Invasion in Metastatic Lymph Nodes in Patients With Prostate Cancer
by: Hirotaka Nagasaka, et al.
Published: (2024)

Establishment and Characterization of Patient‐Derived Xenograft Organoids for Personalized Treatment of Castration‐Resistant Prostate Cancer
by: Takuro Sunada, et al.
Published: (2026)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
by: Cameron J. Britton, et al.
Published: (2025)

Efficacy of Treatments for T3bN0M0 Prostate Cancer Patients: A Systematic Review and Meta‐Analysis
by: Casper Reijnen, et al.
Published: (2025)

Hormone Therapy Usage Is Associated With Adverse Cardiovascular Events in Prostate Cancer Patients of the All of Us Research Program Cohort
by: Yuanchu J. Yang, et al.
Published: (2025)

Comments on the Study “Evaluating the Efficacy of Barley Water in Alleviating Radiotherapy‐Induced Dysuria in Prostate Cancer Patients”
by: Leibo Wang, et al.
Published: (2026)

Altered Glycosylation of PSA in Prostate Cancer Tissue
by: Hannu Koistinen, et al.
Published: (2025)

A Feasibility Study of the Repurposing of Prazosin to Improve Treatment Outcomes in Men Receiving Radiotherapy for Prostate Cancer (MiniRaP‐00)
by: Liam D. King, et al.
Published: (2026)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
by: Haotian Chen, et al.
Published: (2025)

LHRH Antagonists Restore Serum Testosterone Faster Than LHRH Agonists in Prostate Cancer Patients After Radiotherapy
by: Sangjon Pae, et al.
Published: (2025)